Zhuge Ruiqi, Zhou Rong, Ni Xinhai
National Center for Cardiovascular Disease,Department of Cardiology,Fuwai Hospital,CAMS and PUMC,Beijing 100037,China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):438-444. doi: 10.3881/j.issn.1000-503X.2017.03.024.
Mitochondria plays a key role in providing ATP for the energy-consuming cardiac tissues. Mitochondrial cardiomyopathy is a myocardial condition characterized by abnormal heart structure and/or function secondary to genetic defects involving the mitochondrial respiratory chain. The typical cardiac manifestations of mitochondrial cardiomyopathy include hypertrophic and dilated cardiomyopathy,while left ventricular myocardial noncompaction is less common. Recent research has suggested that most mitochondrial diseases result from mitochondrial DNA mutation,which can be found in genes that encode ancillary proteins needed for genetic transcription (tRNA),in genes that encode subunits of the electron transport chain complexes,or in genes that control the activities of the mitochondria called D-loop zone. However,the exact physiological mechanisms remain unclear. This review summarizes the recent advances in the molecular mechanism of mitochondrial cardiomyopathy.
线粒体在为耗能的心脏组织提供三磷酸腺苷(ATP)方面发挥着关键作用。线粒体心肌病是一种心肌疾病,其特征是继发于涉及线粒体呼吸链的遗传缺陷的心脏结构和/或功能异常。线粒体心肌病的典型心脏表现包括肥厚型和扩张型心肌病,而左心室心肌致密化不全则较少见。最近的研究表明,大多数线粒体疾病是由线粒体DNA突变引起的,这些突变可在编码基因转录所需辅助蛋白(tRNA)的基因中、编码电子传递链复合物亚基的基因中或控制线粒体活性的称为D环区的基因中发现。然而,确切的生理机制仍不清楚。本文综述了线粒体心肌病分子机制的最新研究进展。